Company profile · federal money
DFH Pharma, Inc.
DFH Pharma, Inc. received $986.9K in federal awards in FY2025. Largest customer: Department of Health and Human Services ($986.9K).
- FY2025 federal obligations
- $986.9K
Largest customers: Department of Health and Human Services $986.9K
Data through 2026-09-30; source: USAspending.gov.
Gathering everything on record…
From public government records, which may contain errors. Check the official source before relying on a number. Not financial, legal or investment advice. Terms · About the data
SBIR & STTR awards
4 small-business research awards (2 Phase II) worth $2.29M, 2013–2025.
- IND-Enabling Development of HIV Maturation Inhibitors Formulated for use as either Oral or Long-Acting Parenterally Administered Agents Department of Health and Human Services · SBIR Phase II · $986.9K · 2025
- Preclinical Development of 2nd Generation HIV Maturation Inhibitors Department of Health and Human Services · STTR Phase II · $943.1K · 2020
- Preclinical Development of 2nd Generation HIV Maturation Inhibitors Department of Health and Human Services · STTR Phase I · $171.5K · 2018
- Preparation and Characterization of 2nd Generation HIV-1 Maturation Inhibitor Dru Department of Health and Human Services · STTR Phase I · $186.4K · 2013
All of its SBIR & STTR awards · SBA's SBIR.gov data